Price $11.67 |
Market Cap
10.71B
|
Sector Health Care |
Div. Growth
4.30%
|
|
P/E
6.1
|
P/B
0.53
|
P/S
0.71
|
Dividend %
5.20%
|
|
P/CF
-
|
P/FCF
7.2
|
Op. Cash Flow
2.5M
|
FCF
1.2
|
|
Op. Margin
6.70%
|
Net Margin
11.90%
|
ROE
9.00%
|
ROI
2.20%
|
|
ROA
3.80%
|
EPS Growth
144.00%
|
Current Ratio
1.6
|
Debt/Equity
85.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
